advertisement
Labbé A 11
Showing records 1 to 11 | Display all abstracts from Labbé A91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Konstas AG
Expert Opinion on Drug Safety 2021; 0: 1-14
91457 An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma
Souissi S
Acta Ophthalmologica 2021; 99: e621-e653
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Labbé A
Expert Opinion on Drug Safety 2021; 0: 1-14
91457 An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma
Le Mer Y; Metge F
Acta Ophthalmologica 2021; 99: e621-e653
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Katsanos A
Expert Opinion on Drug Safety 2021; 0: 1-14
91457 An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma
Portmann A
Acta Ophthalmologica 2021; 99: e621-e653
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Meier-Gibbons F; Irkec M
Expert Opinion on Drug Safety 2021; 0: 1-14
91457 An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma
Baudouin C; Labbé A
Acta Ophthalmologica 2021; 99: e621-e653
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
Boboridis KG; Holló G
Expert Opinion on Drug Safety 2021; 0: 1-14
91457 An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma
Hamard P
Acta Ophthalmologica 2021; 99: e621-e653
91474 The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability
García-Feijoo J; Dutton GN; Baudouin C
Expert Opinion on Drug Safety 2021; 0: 1-14
